Skip to main content
. 2019 Jun 11;8:e44071. doi: 10.7554/eLife.44071

Table 2. HPLC purification conditions for the peptides used in this study.

Peptide HPLC column Flow rate Gradient
F Phenomenex C4 Luna (100 Å, 10 μm, 10 × 250 mm) 5 mL/min 20 to 80% Buffer B
F12 Phenomenex C12 Jupiter (90 Å, 10 μm, 21.2 × 250 mm) 5 mL/min 25 to 45% Buffer B
F30 Phenomenex C12 Jupiter (90 Å, 10 μm, 21.2 × 250 mm) 10 mL/min 20 to 45% Buffer B
cF30 (pre-cyclization) Phenomenex C12 Jupiter (90 Å, 10 μm, 21.2 × 250 mm) 10 mL/min 20 to 45% Buffer B
cF30 Phenomenex C4 Jupiter (100 Å, 10 μm, 10 × 250 mm) 5 mL/min 10 to 35% Buffer B
FF30 Phenomenex C12 Jupiter (90 Å, 10 μm, 21.2 × 250 mm) 10 mL/min 29 to 37% Buffer B
cFF30 (pre-cyclization Phenomenex C12 Jupiter (90 Å, 10 μm, 21.2 × 250 mm) 10 mL/min 20 to 45% Buffer B
cFF30 Phenomenex C4 Jupiter (100 Å, 10 μm, 10 × 250 mm) 5 mL/min 27 to 38% Buffer B